Literature DB >> 20424625

Anemia: What can we learn from a secondary analysis of CHOIR?

Walter H Hörl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20424625     DOI： 10.1038/nrneph.2010.22

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Does TREAT give the boot to ESAs in the treatment of CKD anemia?

Authors:  Ajay K Singh
Journal:  J Am Soc Nephrol       Date:  2009-12-24       Impact factor: 10.121

2.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

3.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

Authors:  A Besarab; W K Bolton; J K Browne; J C Egrie; A R Nissenson; D M Okamoto; S J Schwab; D A Goodkin
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

4.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

5.  Ferric carboxymaltose in patients with heart failure and iron deficiency.

Authors:  Stefan D Anker; Josep Comin Colet; Gerasimos Filippatos; Ronnie Willenheimer; Kenneth Dickstein; Helmut Drexler; Thomas F Lüscher; Boris Bart; Waldemar Banasiak; Joanna Niegowska; Bridget-Anne Kirwan; Claudio Mori; Barbara von Eisenhart Rothe; Stuart J Pocock; Philip A Poole-Wilson; Piotr Ponikowski
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

6.  Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Authors:  Lynda A Szczech; Huiman X Barnhart; Jula K Inrig; Donal N Reddan; Shelly Sapp; Robert M Califf; Uptal D Patel; Ajay K Singh
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

7.  A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.

Authors:  Lynda A Szczech; Huiman X Barnhart; Shelly Sapp; G Michael Felker; Adrian Hernandez; Donal Reddan; Robert M Califf; Jula K Inrig; Uptal D Patel; Ajay K Singh
Journal:  Kidney Int       Date:  2009-11-04       Impact factor: 10.612

8.  Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.

Authors:  Jalal K Ghali; Inder S Anand; William T Abraham; Gregg C Fonarow; Barry Greenberg; Henry Krum; Barry M Massie; Scott M Wasserman; Marie-Louise Trotman; Yan Sun; Beat Knusel; Paul Armstrong
Journal:  Circulation       Date:  2008-01-14       Impact factor: 29.690

9.  Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.

Authors:  Dirk J van Veldhuisen; Kenneth Dickstein; Alain Cohen-Solal; Dirk J A Lok; Scott M Wasserman; Nigel Baker; Dylan Rosser; John G F Cleland; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2007-08-06       Impact factor: 29.983

10.  The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.

Authors:  Victor E Pollak; Jonathan A Lorch; Rakesh Shukla; Supriya Satwah
Journal:  BMC Nephrol       Date:  2009-02-26       Impact factor: 2.388
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.